CML
News
CHMP backs approval of dasatinib for kids
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended changes to the marketing authorization for...
From the Journals
Do industry payments increase prescribing for some targeted therapies?
Some oncologists prescribing treatments for CML and RCC were more likely to prescribe a drug when they had received general payments from the drug...
News
Agent exhibits activity in leukemias, MDS
The experimental agent prexigebersen (formerly BP1001) was considered well-tolerated and demonstrated early evidence of activity against relapsed/...
News
FDA approves nilotinib for children with CML
The decision expands the drug’s indication to include first- and second-line use in children.
News
FDA approves nilotinib for kids with CML
The US Food and Drug Administration (FDA) has expanded the approved indication for nilotinib (Tasigna®) to include the treatment of children. The...
News
Ponatinib efficacy maintained despite dose reductions
Final results from the phase 2 PACE trial suggest dose reductions did not have an effect on the efficacy of ponatinib in patients with chronic...
From the Journals
A global snapshot of leukemia incidence
United States is on the high side for all four subtypes of the disease.
From the Journals
TFR achievable with second-line nilotinib for chronic CML
The phase 2 study showed high rates of treatment-free remission in patients who achieved a sustained molecular response.
News
Drug could improve treatment of CML, team says
A microRNA-targeting drug could improve the effectiveness of tyrosine kinase inhibitors (TKIs) against chronic myelogenous leukemia (CML),...
News
CHMP backs bosutinib for newly diagnosed CML
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the approved use of bosutinib (...
Conference Coverage
Expanded UCB product can stand alone
SALT LAKE CITY—The expanded umbilical cord blood (UCB) product NiCord can be used as a stand-alone graft, according to research presented at the...